This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Graziani, I. Articles by Bocchetta, M. Search for Related Content PubMed PubMed Citation Articles by Graziani, I. Articles by Bocchetta, M.

Opposite Effects of Notch-1 and Notch-2 on Mesothelioma Cell Survival under Hypoxia Are Exerted through the Akt Pathway

¹ Department of Pathology and Oncology Institute, Loyola University Chicago, Cancer Center, Maywood, Illinois; ² Departments of Cardiothoracic Surgery and Surgery, New York University Medical Center, New York, New York; ³ Department of Pathology, The University of Chicago, Chicago, Illinois; and ⁴ Department of Cancer Biology and Therapeutics, Merck Research Laboratories, Boston, Massachusetts

Requests for reprints: Maurizio Bocchetta, Oncology Institute, Loyola University Chicago, 2160 South First Avenue, Building 112, Room 204, Maywood, IL 60153. Phone: 708-327-3362; Fax: 708-327-3228; E-mail: mbocche{at}lumc.edu.

Key Words: Notch signaling • Akt • apoptosis • hypoxia • mesothelioma • -secretase inhibitors

Malignant mesothelioma (MM) is a cancer of the lining of the lungs, heart, and intestine and is known to respond poorly to chemotherapy. Here we show that malignant mesothelial cells have an elevated Notch signaling pathway compared with normal human mesothelial cells. We studied the role of Notch in MM under normoxic and hypoxic conditions, the latter condition best recapitulating the MM microenvironment. Genetic and chemical modulation of the Notch pathway indicated that MM cells are dependent on Notch signaling. More specifically, this signaling was Notch-1 dependent as the result of its negative transcriptional regulation on phosphatase and tensin homologue (PTEN), which led to activation of the prosurvival phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling pathway. Our study also provides evidence that whereas Notch-1 is elevated in the malignant setting, Notch-2 is diminished. This differential expression of the two Notch isoforms benefits cancer cell survival because reexpression of Notch-2 was toxic to MM cells. The mechanism of Notch-2 toxicity to MM cells countered that of Notch-1, as it was the result of positive transcriptional regulation of PTEN and inhibition of the PI3K/Akt/mTOR signaling pathway. These results provide new insight into the role of Notch in MM and suggest that Notch pathway inhibitors may be useful in the treatment of this deadly disease. [Cancer Res 2008;68(23):9678–85]